martes, 11 de mayo de 2010

Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): vita


GUIDELINE TITLE
Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.

BIBLIOGRAPHIC SOURCE(S)
Harden CL, Pennell PB, Koppel BS, Hovinga CA, Gidal B, Meador KJ, Hopp J, Ting TY, Hauser WA, Thurman D, Kaplan PW, Robinson JN, French JA, Wiebe S, Wilner AN, Vazquez B, Holmes L, Krumholz A, Finnell R, Shafer PO, Le Guen C. Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Report of the Quality Standards Subcommittee [trunc]. Neurology 2009 Jul 14;73(2):142-9. [45 references] PubMed


GUIDELINE STATUS
This is the current release of the guideline.

** REGULATORY ALERT **
FDA WARNING/REGULATORY ALERT
Note from the National Guideline Clearinghouse:
This guideline references a drug(s) for which important revised regulatory and/or warning information has been released.

December 3, 2009 - Valproate sodium (valproic acid and divalproex sodium): The U.S. Food and Drug Administration (FDA) notified health care professionals and patients about the increased risk of neural tube defects and other major birth defects, such as craniofacial defects and cardiovascular malformations, in babies exposed to valproate sodium and related products (valproic acid and divalproex sodium) during pregnancy. Healthcare practitioners should inform women of childbearing potential about these risks, and consider alternative therapies, especially if using valproate to treat migraines or other conditions not usually considered life-threatening.

open here to see the full-text:
Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): vita

No hay comentarios:

Publicar un comentario